Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients

Molecular Vision

Volumn 21, Issue , 2015, Pages 649-664

  Brzović Šarić, Vlatka ^a   Landeka, Irena ^b   Šarić, Borna ^a   Barberić, Monika ^a   Andrijašević, Lidija ^a   Cerovski, Branimir ^c   Oršolić, Nada ^b   Đikić, Domagoj ^b  

^a Croatian Academy of Medical Sciences   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; VASCULOTROPIN; ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LIPID PEROXIDE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; VITRECTOMY; VITREOUS BODY; BLOOD; CASE CONTROL STUDY; DIABETIC RETINOPATHY; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADVANCED OXIDATION PROTEIN PRODUCTS; AGED; AGED, 80 AND OVER; BIOMARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GLUTATHIONE; HUMANS; LIPID PEROXIDES; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 84935891199     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. International Diabetes Federation. IDF Diabetes atlas. V edition. http://wwwidforg/diabetesatlas/5e/ Update 2012. Accessed September 28. 2013.
2. Haskins K, Bradley B, Powers K, Fadok V, Flores S, Ling X, Pugazhenthi S, Reusch J, Kench J. Oxidative stress in type 1 diabetes. Ann N Y Acad Sci 2003; 1005:43-54. [PMID: 14679039]
3. Kowluru RA, Chan PS. Oxidative stress and diabetic reti­nopathy. Exp Diabetes Res 2007; [PMID: 17641741]
4. Chew EY, Ferris FL. Nonproliferative diabetic retinopathy in: Ryan SJ (Eds) Retina 2001; 3rd edn. St Louis Mosby pp 1295–08
5. Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350:48-58. [PMID: 14702427]
6. Aylward GW. Progressive changes in diabetics and their management. Eye (Lond) 2005; 19:1115-8. [PMID: 16304592]
7. Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinop­athy. Diabetes Care 2004; 27:2540-53. [PMID: 15451934]
8. El-Remessy AB, Franklin T, Ghaley N, Yang J, Brands MW, Caldwell RB, Behzadian MA. Diabetes-induced superoxide anion and breakdown of the blood-retinal barrier: role of the VEGF/uPAR pathway. PLoS ONE 2013; 8:e71868. [PMID: 23951261]
9. Castorina C, Campisi A, Di Giacomo C, Sorrenti V, Russo A, Vanella A. Lipid peroxidation and antioxidant enzymatic systems in rat retina as a function of age. Neurochem Res 1992; 17:599-604. [PMID: 1603266]
10. Obrosova IG, Drel VR, Kumagai AK, Szábo C, Pacher P, Stevens MJ. Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models. Diabeto­logia 2006; 49:2525-33. [PMID: 16896942]
11. Johnsen-Soriano S, Garcia-Pous M, Arnal E, Sancho-Tello M, Garcia-Delpech S, Miranda M, Bosch-Morell F, Diaz-Llopis M, Navea A., Romero F J. Early lipoic acid intake protects retina of diabetic mice Free Radic Res 2008; 42:613-7. [PMID: 18608516]
12. Skeie JM, Mahajan VB. Proteomic Interactions in the Mouse Vitreous-Retina Complex. PLoS ONE 2013; 8:11-[PMID: 24312404]
13. Chiang SY, Tsai ML, Wang CY, Chen A, Chou YC, Hsia CW, Wu YF, Chen HM, Huang TH, Chen PH, Liu HT, Shui HA. Proteomic analysis and identification of aqueous humor proteins with a pathophysiological role in diabetic reti­nopathy. J Proteomics 2012; 75:2950-9. [PMID: 22200677]
14. Oršolić N, Gajski G, Garaj-Vrhovac V, Đikić D, Špacir Prskalo Z, Sirovina D. DNA-protective effects of quercetin or narin­genin in alloxan-induced diabetic mice. Eur J Pharm 2011; 656:110-8. [PMID: 21277296]
15. Kiang AS, Humphries MM, Campbell M, Humphries P. Anti­oxidant therapy for retinal disease. Adv Exp Med Biol 2014; 801:783-9. [PMID: 24664771]
16. Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des 2008; 14:962-8. [PMID: 18473846]
17. Yildirim Z, Uçgun NI, Kiliç N, Gürsel E, Sepici-Dinçel A. Antioxidant enzymes and diabetic retinopathy. Ann N Y Acad Sci 2007; 1100:199-206. [PMID: 17460179]
18. Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K. Antioxidant status lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003; 36:557-62. [PMID: 14563450]
19. Pan HZ, Zhang H, Chang D, Li H, Sui H. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 2008; 92:548-51. [PMID: 18369071]
20. Verdejo C, Marco P, Renau-Piqueras J, Pinazo-Duran MD. Lipid peroxidation in proliferative vitreoretinopathies. Eye (Lond) 1999; 13:183-8. [PMID: 10450379]
21. World Health Organization (WHO). Report of a WHO Consultation Definition diagnosis and classification of diabetes mellitus and its complications Diagnosis and clas­sification of diabetes mellitus. WHO/NCD/NCS/992 Geneva WHO 1999; p. 1–49 http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf
22. Early Treatment of Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color funds photographs - An extension of the modified Airline House classification. Ophthalmology 1991; 98:Suppl786-806. [PMID: 2062513]
23. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidizedglutathione (GSH): Applications to mammalian blood and other tissues. Anal Biochem 1969; 27:502-22. [PMID: 4388022]
24. Praidou A, Papakonstantinou E, Androudi S, Georgiadis N, Karakiulakis G, Dimitrakos S. Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema. Acta Ophthalmol (Copenh) 2011; 89:248-54. [PMID: 19799585]
25. Endo M, Yanagisawa K, Tsuchida K, Okamoto T, Matsushita T, Higuchi M, Matsuda A, Takeuchi M, Makita Z, Koike T. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy. Horm Metab Res 2001; 33:317-22. [PMID: 11440280]
26. Izuta H, Matsunaga N, Shimazawa M, Sugiyama T, Ikeda T, Hara H. Proliferative diabetic retinopathy and relations among antioxidant activity oxidative stress and VEGF in the vitreous body. Mol Vis 2010; 16:130-6. [PMID: 20142849]
27. Baskol G. Gumus K, Oner A, Arda H, Karakucuk S. The role of advanced oxidation protein products and total thiols in diabetic retinopathy. Eur J Ophthalmol 2008; 18:792-8. [PMID: 18850560]
28. Oettl K, Reibnegger G, Schmut O. The redox state of human serum albumin in eye diseases with and without complica­tions. Acta Ophthalmol (Copenh) 2011; 89:e174-9. [PMID: 20064117]
29. Loukovaara S, Koivunen P, Ingles M, Escobar J, Vento M, Andersson S. Elevated protein carbonyl and HIF-1 alpha levels in eyes with proliferative diabetic retinopathy. Acta Ophthalmol (Copenh) 2014; 92:323-7
30. Choudhuri S, Mandal LK, Paine SK, Sen A, Dutta D, Chow­dhury IH, Mukherjee A, Saha A, Bhadhuri G, Bhattacharya B. Role of hyperglycemia-mediated erythrocyte redox state alteration in the development of diabetic retinopathy. Retina 2013; 33:207-16. [PMID: 22653543]
31. Choudhuri S, Dutta D, Sen A, Chowdhury IH, Mitra B, Mondal LK, Saha A, Bhadhuri G, Bhattacharya B. Role of N-epsilon-carboxy methyl lysine advanced glycation end products and reactive oxygen species for the development of nonprolifera­tive and proliferative retinopathy in type 2 diabetes mellitus. Mol Vis 2013; 19:100-13. [PMID: 23378723]
32. Cicik E, Tekin H, Akar S, Ekmekçi OB, Donma O, Koldaş L, Ozkan S. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ophthalmic Res 2003; 35:251-5. [PMID: 12920337]
33. Wright WS, McElhatten RM, Busu C, Amit SY, Leskova W, Aw TY, Harris NR. Influence of glutathione on the electro­retinogram in diabetic and non-diabetic rats. Curr Eye Res 2011; 36:831-7. [PMID: 21851169]
34. Ola MS, Ahmed MM, Abuohashish HM, Al-Rejaie SS, Alhomida AS. Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats. Neurochem Res 2013; 38:1572-9. [PMID: 23624827]
35. Kamegawa M, Nakanishi-Ueda T, Iwai S, Ueda T, Kosuge S, Ogura H, Sasuga K, Inagaki M, Watanabe M, Oguchi K, Yasuhara H, Armstrong D, Koide R. Effect of lipid-hydro­peroxide-induced oxidative stress on vitamin E, ascorbate and glutathione in the rabbit retina. Ophthalmic Res 2007; 39:49-54. [PMID: 17164578]
36. Mandal LK, Choudhuri S, Dutta D, Mitra B, Kundu S, Chow­dhury IH, Sen A, Chatterjee M, Bhattacharya B. Oxidative stress-associated neuroretinal dysfunction and nitrosative stress in diabetic retinopathy. Can J Diabetes 2013; 37:401-7. [PMID: 24321721]
37. Mancino R, Di Pierro D, Varesi C, Cerulli A, Feraco A, Cedrone C, Pinazo-Duran MD, Coletta M, Nucci C. Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy. Mol Vis 2011; 17:1298-304. [PMID: 21633716]
38. Gupta MM, Chari S. Lipid peroxidation and antioxidant status in patients with diabetic retinopathy. Indian J Physiol Phar­macol 2005; 49:187-92. [PMID: 16170987]
39. Saxena S, Srivastava P, Khanna VK. Elevated lipid peroxides induced angiogenesis in proliferative diabetic retinopathy. J Ocul Biol Dis Infor 2010; 3:85-7. [PMID: 22708001]
40. Izuta H, Chikaraishi Y, Adachi T, Shimazawa M, Sugiyama T, Ikeda T, Hara H. Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients. Mol Vis 2009; 15:2663-72. [PMID: 20011081]
41. Sözmen EY, Sözmen B, Delen Y, Onat T. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. Arch Med Res 2001; 32:283-7. [PMID: 11440784]
42. Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 2004; 24:1367-73. [PMID: 15166009]
43. Santos JM, Mohammad G, Zhong Q, Kowluru RA. Diabetic retinopathy superoxide damage and antioxidants. Curr Pharm Biotechnol 2011; 12:352-61. [PMID: 20939803]
44. Du Y, Miller CM, Kern TS. Hyperglycemia increases mito­chondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003; 35:1491-9. [PMID: 14642397]
45. Barathi S, Angayarkanni N, Pasupathi A, Natarajan SK, Pukraj R, Dhupper M, Velpandian T, Muralidharan C, Sivashan­mugham M. Homocysteinethiolactone and paraoxonase: novel markers of diabetic retinopathy. Diabetes Care 2010; 33:2031-7. [PMID: 20551012]